Zhou Y, Kaiser T, Monteiro P, et al. Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects. Neuron. 2016;89(1):147-62. doi:10.1016/j.neuron.2015.11.023
Wright J. Genetics: Unravelling complexity. Nature. 2014;508(7494):S6-7. doi:10.1038/508S6a
Fan JB, Sklar P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry. 2005;10(10):928-38, 891. doi:10.1038/sj.mp.4001690
Rees E, Kirov G, Sanders A, et al. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatry. 2014;19(1):37-40. doi:10.1038/mp.2013.156
Agerbo E, Sullivan PF, Vilhjálmsson BJ, et al. Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysis. JAMA Psychiatry. 2015;72(7):635-41. doi:10.1001/jamapsychiatry.2015.0346
Richards AL, Leonenko G, Walters JT, et al. Exome arrays capture polygenic rare variant contributions to schizophrenia. Hum Mol Genet. 2016;25(5):1001-7. doi:10.1093/hmg/ddv620
Hill K, Buchholz A, Amsbaugh H, et al. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. Schizophr Res. 2015;166(1-3):310-5. doi:10.1016/j.schres.2015.05.018
Petryshen TL, Middleton FA, Kirby A, et al. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry. 2005;10(4):366-74, 328. doi:10.1038/sj.mp.4001608
Duncan LE, Holmans PA, Lee PH, et al. Pathway analyses implicate glial cells in schizophrenia. PLoS One. 2014;9(2):e89441. doi:10.1371/journal.pone.0089441
Migliavacca E, Golzio C, Männik K, et al. A Potential Contributory Role for Ciliary Dysfunction in the 16p11.2 600 kb BP4-BP5 Pathology. Am J Hum Genet. 2015;96(5):784-96. doi:10.1016/j.ajhg.2015.04.002